(Q44233161)

1 December 2017

title

Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings (English)

1 reference

1 December 2017

2

Murat Kuloglu

1 reference

1 December 2017

1

Murad Atmaca

1 reference

1 December 2017

3

Ertan Tezcan

1 reference

1 December 2017

Ahmet Unal

4

1 reference

1 December 2017

publication date

1 December 2002

1 reference

1 December 2017

published in

Human Psychopharmacology

1 reference

1 December 2017

volume

17

1 reference

1 December 2017

issue

8

1 reference

1 December 2017

page(s)

401-405

1 reference

Fluoxetine and side effects

1 December 2017

cites work

1 reference

The assessment of anxiety states by rating

21 January 2018

1 reference

Role of GABA in memory and anxiety

21 January 2018

1 reference

Social phobia subtypes in the National Comorbidity Survey.

21 January 2018

1 reference

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

21 January 2018

1 reference

The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat.

21 January 2018

1 reference

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

21 January 2018

1 reference

Different ages of onset in varieties of phobia

21 January 2018

1 reference

Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group

21 January 2018

1 reference

7 January 2021

The neurobiology of social phobia

1 reference

7 January 2021

Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia

1 reference

7 January 2021

Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.

1 reference

7 January 2021

Citalopram in the treatment of social phobia: a report of three cases

1 reference

7 January 2021

Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study

1 reference

7 January 2021

Moclobemide in social phobia: a controlled dose-response trial

1 reference

7 January 2021

Effects of selective serotonin reuptake inhibitors on sexual function

1 reference

7 January 2021

Placebo-controlled trial of moclobemide in social phobia

1 reference

7 January 2021

Citalopram for social phobia: a clinical case series

1 reference

7 January 2021

Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation.

1 reference

7 January 2021

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

7 January 2021

Functional brain imaging and pharmacotherapy in social phobia: single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram

1 reference

7 January 2021

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

1 reference

7 January 2021

Social phobia: long-term treatment outcome and prediction of response--a moclobemide study

1 reference

7 January 2021

Pharmacotherapy of Social Phobia

1 reference

7 January 2021

Social phobia in general health care: an unrecognised undertreated disabling disorder

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.436

1 reference

1 December 2017

1 reference